Clinico-pathological Analysis of Cervical Pap Smear in Patients Attending Gynecology OPD of a Medical College
Abstract
Background: Cervical cancer ranks the most common cancer among Nepalese women. Cervical and vaginal infections constitute the most common gynecological problems. Through Pap smear screening, early diagnosis, follow up and treatment, morbidity and mortality can be reduced by 70% and 80% respectively.
Methods: This retrospective study was conducted to know the incidence of abnormal cervical epithelial lesions and cervico-vaginal infections. It was carried out in the Outpatient Department of Gynecology at Chitwan Medical College from April 2018 to March 2019. The data were collected and standard statistical analysis done using Microsoft Excel 2007.
Results: The most prevalent cervical epithelial cell abnormality was atypical squamous cells of undetermined significance (3.43%) whereas the least common was low grade squamous intraepithelial lesion (0.21%). The most prevalent cervical vaginal infection was Bacterial vaginosis (12.30%) whereas the least prevalent was Trichomoniasis (0.29%). The majority of the women with epithelial cell abnormality were in the age group of 31-40 years whereas the lowest number in the age group less than 20 years. The highest prevalence of cervical vaginal infection was in the reproductive age group (31-50 years) and the lowest in the age above 51 years. Most of the patients had multiple symptoms like vaginal discharge, genital itching, whereas only (20.17%) visited for routine screening.
Conclusion: Atypical squamous cells of undetermined significance and Bacterial vaginosis were the most common finding in Pap smear test representing abnormal cytology of cervix and cervicovaginal infection respectively.
References
2. Tamrakar SR, Chawla CD. A Clinical Audit of Pap Smear Test for Screening of Cervical Cancer. NJOG. 2012;7(2):21-4. https://doi.org/10.3126/njog.v7i2.11137
3. Family Health Division (FDH). National Guideline for Cervical Cancer Screening and Prevention in Nepal [Internet]. 2011 [cited 18 Aug 2020]. Available from: http://whonepal.healthrepository.org/bitstream/123456789/498/1/National%20Guideline%20for%20CCSP.pdf
4. ICO Information Centre on HPV and Cancer. Nepal Human Papillomavirus and Related Cancers Fact Sheet 2017 [Internet]. 2017 [cited 18 Aug 2020]. Available from: http://hpvcentre.net/statistic/reports/NPL_FS.pdf
5. National Cancer Registry Program. Hospital based cancer registry 10 years consolidated report (2003-2012) [Internet]. 2015[cited 18 Aug 2020]. Available from: http://www.bpkihs.edu/
6. National Cancer Registry Program. Report of hospital-based cancer registry 2015 [Internet]. 2015 [cited 21 January 2020] Available: www.bpkmch.org.np.
7. Vijaya LP, SreeGouri SR. Study and Analysis of Two Hundred Cervical PAP Smears in Our Hospital. Int J of Contemporary Med Res. 2016;3(9):2787-9. https://www.ijcmr.com/uploads/7/7/4/6/77464738/ijcmr_939_v1_sep_22__1__3.pdf
8. Bamanikar SA, Chandanwale SS, Baravkar DS, Dapkekar P. Study of Cervical Pap Smears in a Tertiary Hospital. Indian Medical Gazette. 2014;148(7):250-4.
9. World Health Organization (WHO) (2017). Strategic framework for the comprehensive control of cancer cervix in South- East Asia Region [Internet]. 2015 [cited 18 Aug 2020]. Available from: http://apps.who.int/iris/bitstream/10665/152098/1/9789290224723-MRH .pdf.
10. Dhakal S. Oncoprevention in gynecology. JNMA J Nepal Med Assoc. 2010;49(178):167-73. https://doi.org/10.31729/jnma.126
11. Alliance for cervical cancer prevention. Pap smear: An important but imperfect screening method. http://screening.iarc.fr/doc/Rh_pap_smears.pdf. (2020/8/18)
12. Adad SJ, De Lima RV, Sawan ZT, Silva ML, De Souza MA, et al. Frequency of Trichomonas vaginalis, Candida sp and Gardnerella vaginalis in cervical -vaginal smears in four different decades. Sao Paulo Med J. 2001;119:200-205.
https://doi.org/10.1590/S1516-31802001000600004
13. Heller DS, Pitsos M, Skurnick J. Does the presence of vaginitis on a Pap smear correlate with clinical symptoms in the patient? J Reprod Med. 2008;53:429-34. https://pubmed.ncbi.nlm.nih.gov/18664061/
14. Ramadevi E MN, Madhavi G B, Sudha Rani V, Padmalatha R, Shamili G. A study of correlation between cytology and histopathology with colposcopic findings. Int J Intg Med Sci. 2017;4:477-83. https://doi.org/10.16965/ijims.2017.105
15. Rathod GB SD. Histopathological vs Cytological Findings in Cervical Lesions (Bethesda System) - A Comparative Study. IAM. 2015;2(8):13-6. https://iaimjournal.com/wp-content/uploads/2015/08/iaim_2015_0208_02.pdf
16. Wright TC. Cervical Cancer Screening in the 21st Century: is it Time to Retire the PAP Smear? Clin Obstet Gynecol. 2007;50(2):313-23. https://doi.org/10.1097/GRF.0b013e31804a8285
17. Ranabhat SK, Shrestha R, Tiwari M. Analysis of Abnormal Epithelial Lesions in Cervical Pap Smears in Mid- Western Nepal. Journal of Pathology of Nepal. 2011;1:30-33. DOI:
https://doi.org/10.3126/jpn.v1i1.4447
18. Sarma U, Mahanta J, Talukdar K. Pattern of Abnormal Cervical Cytology in Women Attending Tertiary Hospital. Int J Sci Res Pub. 2012;2(12):1-4. http://www.ijsrp.org/research-paper-1212/ijsrp-p1256.pdf
19. Alta BL, Prasad U, Shamili M, S. Satish kumar. Cytological Patterns of Cervical Pap Smears with Histopathological Correlation. Int J Res Med Sci. 2015;3(8):1911-1961. DOI: https://doi.org/10.18203/2320-6012.ijrms20150300
20. Laxmi RC, Shrestha P, Pradhan B. Analysis of Cervical Cancer Screening at Patan Hospital Nepal. JCMC. 2018;8(23):1-4. https://doi.org/10.3126/jcmc.v8i1.23707
21. Vaghela BK, Vaghela VK, Santawani PM. Analysis of Abnormal Cervical Cytology in Papanicolaou Smears at Tertiary Care Center- A Retrospective Study. IJBAR. 2014;5(1):47-9. https://doi.org/10.7439/ijbar.v5i1.55
22. Ramu S, Bindu BJ, Murthy N. Pap Smear as Early Diagnostic Tool for Cervical Cancer- A Life Saviour. Trop J Path Micro. 2018;4(1):22-6. https://doi.org/10.17511/jopm.2018.i01.04
23. Patel CB, Shah PC, Bhagat VM. A Role of Cervical Pap Smear as a Screening Tool in Diagnosis of Lesions of Cervix- A One- year Study. International Journal of Medical Science and Public Health. 2016 Sept 1;5(9):1841-5. https://doi.org/10.5455/ijmsph.2016.30122015340
24. Tailor HJ, Patel RD, Patel PR, Bhagat VM. Study of Cervical Pap Smear in a Tertiary Care Hospital of South Gujarat, India. Int J Res Med Sci. 2016 Jan;4(1):286-288. https://doi.org/10.18203/2320-6012.ijrms20160044
25. Saha K, Sengupta M, Mistry CJ. Cytological findings of Conventional Cervical Papanicolaou Smear in a Tertiary Care Hospital. Global Research Analysis. 2013;2:149-151. https://doi.org/10.15373/22778160
26. Renuka N, Sultana A. Cytopathological Study of Cervical Smear: A Hospital Based Retrospective Study. Medical Journal of Islamic World Academy of Sciences. 2014;22(1):42-9. https://doi.org/10.12816/0008170
27. Nair RV, Shwetha BR, Manju A, Solanke PV. Papanicolaou (Pap) Test Screening in a Tertiary Care Teaching Hospital in South India. IJMSCI. 2015;2(8):1260-5.
https://doi.org/10.18535/ijmsci/v2i8.07
28. Selhi PK, Singh A, Kaur H, Sood N. Trends in Cervical Cytology of Conventional Pap Smears According to Revised Bethesda System; A Study of 638 cases. IJRRMS. 2014 Jan-March;4(1):16-20. https://www.semanticscholar.org/paper/Trends-in-cervical-cytology-of-conveno-nal-smears-A-Selhi-Singh/4533818f9f4001d7603fc9ce654f254d74939a0f
29. Verma I, Jain V, Kaur T. Application of Bethesda System for Cervical Cytology in Unhealthy Cervix. J Clin Diagn Res. 2014 Sept;8(9):26-30.
https://doi.org/10.7860/JCDR/2014/9620.4893
30. Mulay k, Swain M, Patra S, Gowrishankar S. A Comparative Study of Cervical Smears in an Urban Hospital in India and a Population-based Screening Program in Mauritius. Indian Journal of Pathology and Microbiology. 2009 Jan 1;52(1):34-37. PMID: 19136776;
https://doi.org/10.4103/0377-4929.44959
31. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam S, Cain et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. Journal of Lower Genital Tract Disease. 2012;16(3):175-204.
https://doi.org/10.1097/LGT.0b013e31824ca9d5
32. Joshi PK C, Thakur N. Correlation of Pap Smear and Colposcopy in Relation to Histopathological Findings in Detection of Premalignant Lesions of Cervix in a Tertiary Care Centre. International J of Scientific Study. 2015;3:55-60. https://www.ijss-sn.com/uploads/2/0/1/5/20153321/ijss_nov_oa13.pdf
33. Dhakal R, Makaju R, Sharma S, Bhandari S, Shrestha S, Bastakoti R. Correlation of Cervical Pap Smear with Biopsy in the Lesion of Cervix. Kathmandu Univ med J. 2016;14:254-257. https://pubmed.ncbi.nlm.nih.gov/28814689/
34. Biocea A, Patrascu A, Surlin V, Iliescu L, Schenker M, Chiutu L. Correlations between Colposcopy and Histologic Results from Colposcopically Directed Biopsy in Cervical Precancerous Lesions. Rom J Morphol Embryol. 2012;53:735-741. PMID: 23188433
35. Mainali N, Homagai N, Nepal N, Choudhary P. A Correlation Study of Cervical Cytology on Pap Smear with Cervical Biopsy in Tertiary Hospital of Eastern Nepal. J Pathol Nep. 2018;8:1389-1392. DOI: https://doi.org/10.3126/jpn.v8i2.20993
https://doi.org/10.3126/jpn.v8i2.20993
Copyright (c) 2021 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author(s) as the copyright holder will retain the ownership of the copyrights without any restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.
On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/
